These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 10519934)

  • 1. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers.
    DiPetrillo MD; Tibbetts T; Kleanthous H; Killeen KP; Hohmann EL
    Vaccine; 1999 Oct; 18(5-6):449-59. PubMed ID: 10519934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of vector-priming on the immunogenicity of a live recombinant Salmonella enterica serovar typhi Ty21a vaccine expressing urease A and B from Helicobacter pylori in human volunteers.
    Metzger WG; Mansouri E; Kronawitter M; Diescher S; Soerensen M; Hurwitz R; Bumann D; Aebischer T; Von Specht BU; Meyer TF
    Vaccine; 2004 Jun; 22(17-18):2273-7. PubMed ID: 15149786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers.
    Angelakopoulos H; Hohmann EL
    Infect Immun; 2000 Apr; 68(4):2135-41. PubMed ID: 10722611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.
    Hohmann EL; Oletta CA; Killeen KP; Miller SI
    J Infect Dis; 1996 Jun; 173(6):1408-14. PubMed ID: 8648213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers.
    Bumann D; Metzger WG; Mansouri E; Palme O; Wendland M; Hurwitz R; Haas G; Aebischer T; von Specht BU; Meyer TF
    Vaccine; 2001 Dec; 20(5-6):845-52. PubMed ID: 11738748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen.
    Londoño-Arcila P; Freeman D; Kleanthous H; O'Dowd AM; Lewis S; Turner AK; Rees EL; Tibbitts TJ; Greenwood J; Monath TP; Darsley MJ
    Infect Immun; 2002 Sep; 70(9):5096-106. PubMed ID: 12183559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers.
    Hohmann EL; Oletta CA; Miller SI
    Vaccine; 1996 Jan; 14(1):19-24. PubMed ID: 8821644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines.
    Aebischer T; Bumann D; Epple HJ; Metzger W; Schneider T; Cherepnev G; Walduck AK; Kunkel D; Moos V; Loddenkemper C; Jiadze I; Panasyuk M; Stolte M; Graham DY; Zeitz M; Meyer TF
    Gut; 2008 Aug; 57(8):1065-72. PubMed ID: 18417532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
    Tacket CO; Kelly SM; Schödel F; Losonsky G; Nataro JP; Edelman R; Levine MM; Curtiss R
    Infect Immun; 1997 Aug; 65(8):3381-5. PubMed ID: 9234801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori infection affects immune responses following vaccination of typhoid-naive U.S. adults with attenuated Salmonella typhi oral vaccine CVD 908-htrA.
    Muhsen K; Pasetti MF; Reymann MK; Graham DY; Levine MM
    J Infect Dis; 2014 May; 209(9):1452-8. PubMed ID: 24273182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological features and efficacy of a multi-epitope vaccine CTB-UE against H. pylori in BALB/c mice model.
    Guo L; Yin R; Liu K; Lv X; Li Y; Duan X; Chu Y; Xi T; Xing Y
    Appl Microbiol Biotechnol; 2014 Apr; 98(8):3495-507. PubMed ID: 24370888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral immunization of mice with attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Liu X; Hu J; Zhang X; Fan D
    Chin Med J (Engl); 2002 Oct; 115(10):1513-6. PubMed ID: 12490099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit.
    Yang XL; Liu WC; Yang WW; Zhong D; Liu YH; Zhang JD; Jiang JH; Li SS
    Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults.
    Michetti P; Kreiss C; Kotloff KL; Porta N; Blanco JL; Bachmann D; Herranz M; Saldinger PF; Corthésy-Theulaz I; Losonsky G; Nichols R; Simon J; Stolte M; Ackerman S; Monath TP; Blum AL
    Gastroenterology; 1999 Apr; 116(4):804-12. PubMed ID: 10092302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic efficacy of oral immunization with attenuated Salmonella typhimurium expressing Helicobacter pylori CagA, VacA and UreB fusion proteins in mice model.
    Liu KY; Shi Y; Luo P; Yu S; Chen L; Zhao Z; Mao XH; Guo G; Wu C; Zou QM
    Vaccine; 2011 Sep; 29(38):6679-85. PubMed ID: 21745524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Phase I, dose-escalation trial in adults of three recombinant attenuated Salmonella Typhi vaccine vectors producing Streptococcus pneumoniae surface protein antigen PspA.
    Frey SE; Lottenbach KR; Hill H; Blevins TP; Yu Y; Zhang Y; Brenneman KE; Kelly-Aehle SM; McDonald C; Jansen A; Curtiss R
    Vaccine; 2013 Oct; 31(42):4874-80. PubMed ID: 23916987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis.
    Lee CK; Weltzin R; Thomas WD; Kleanthous H; Ermak TH; Soman G; Hill JE; Ackerman SK; Monath TP
    J Infect Dis; 1995 Jul; 172(1):161-72. PubMed ID: 7797906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
    Li X; Xing Y; Guo L; Lv X; Song H; Xi T
    Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral Immunization with a Multivalent Epitope-Based Vaccine, Based on NAP, Urease, HSP60, and HpaA, Provides Therapeutic Effect on
    Guo L; Yang H; Tang F; Yin R; Liu H; Gong X; Wei J; Zhang Y; Xu G; Liu K
    Front Cell Infect Microbiol; 2017; 7():349. PubMed ID: 28824883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity characterization of the multi-epitope vaccine CTB-UE with chitosan-CpG as combination adjuvants against Helicobacter pylori.
    Xing Y; Liu W; Li X; Guo L; Lv X; Xi T
    Biochem Biophys Res Commun; 2015 Jul; 462(3):269-74. PubMed ID: 25957472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.